SUNDAY CONFERENCE
Oct
13
9:00 AM09:00

SUNDAY CONFERENCE


9:00 AM

Doors open


9:30 AM

Opening remarks


9:45 AM

Psychedelics in the Media

Shelby Hartman
Editor-in-Chief/Co-Founder, DoubleBlind

Madison Margolin
Managing Editor/Co-Founder, DoubleBlind


10:30 AM

Just for Fun? The Use of Psychedelics in Contemporary Festivals and Nightlife

Fiona Measham
Chair in Criminology, University of Liverpool


11:15 AM

Break


11:30 AM

Panel
Economic Models for the Expansion of Psychedelics

Rachel Aidan, Ph.D. (candidate)
Chief Operations Officer, Synthesis Retreat

George Goldsmith
Executive Chairman, CEO, and Co-founder, COMPASS Pathways

Robert Jesse
Researcher

Beatriz Caiuby Labate, Ph.D.
Executive Director, Chacruna
Public Education and Culture Specialist, MAPS;

Dr. James Rucker
Consultant Psychiatrist and a Senior Clinical Lecturer, Centre for Affective Disorders at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London

Bennet A. Zelner, Ph.D.
Professor and Consultant


1:10 PM

Lunch


2:20 PM

Indigenous Peyote Way of Life

Steven Benally
President of Azee’ Bee Nahagha of Dine Nation formerly known as Native American Church of Navajo Land, National Council of Native American Churches and Board Director of the Indigenous Peyote Conservation Initiative


3:05 PM

Unearthing The Medea: The Intersection of Art and Psychedelic Assisted Therapy

Swoon
Artist and Activist


3:50 PM

Break


4:20 PM

The Challenges and Opportunities of Decriminalizing Psychedelics

Ismail Ali, J.D.
Policy & Advocacy Counsel, MAPS


5:05 PM

All-Speaker Panel


5:50 PM

Adjourn

View Event →
SATURDAY CONFERENCE
Oct
12
9:00 AM09:00

SATURDAY CONFERENCE


9:00 AM

Doors open


9:30 AM

Opening remarks


9:45 AM

LSD Microdosing Study: Psychedelics and Behavioral Effects: What’s in a Dose?

Kim Kuypers, Ph.D.
Researcher and Assistant Professor, Maastricht University, The Netherlands


10:30 AM

Neuroscience Findings from Psilocybin Neuroimaging Studies

Taylor Lyons, Ph.D. (candidate)
Postgraduate Researcher, Psychedelic Research Group, Imperial College, London


11:15 AM

Break


11:30 AM

Clinical Trials on Psilocybin as a Treatment for Major Depressive Disorder

Malynn Utzinger, M.D.
Director of Integrative Medicine, Co-Founder, Usona Institute
Director of Integrative Practices, Promega Corporation


12:15 PM

Psilocybin for Depression: Introducing the ACE Model (Accept, Connect, Embody)

Rosalind Watts, Ph.D.
Clinical Psychologist, Psychedelic Research Group, Imperial College, London

Ashleigh Murphy-Beiner
Assistant Psychologist, Imperial Psychedelic Research Group


1:00 PM

Lunch


2:10 PM

The Potential for Healing and Harm with 5-MeO-DMT

Alan Davis, Ph.D.
Licensed Clinical Psychologist, Assistant Professor at The Ohio State University; Adjunct Assistant Professor at Johns Hopkins University


2:55 PM

Ketamine and Psychiatry

Elias Dakwar, M.D.
Associate Professor of Psychiatry, Columbia University


3:40 PM

Break


4:10 PM

Update on MAPS’ MDMA for PTSD clinical trials

Charlotte Harrison
Clinical Trial Leader, MAPS Public Benefit Corporation


4:55 PM

Dispelling the Lies that the Psychedelic Community Believes About Drugs

Carl Hart, Ph.D
Ziff Professor of Psychology (in Psychiatry), Departments of Psychology and Psychiatry, Columbia University


5:45 PM

Adjourn

View Event →
FRIDAY CLASSES
Oct
11
9:00 AM09:00